Global Infectious Disease Diagnostic Testing Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Infectious Disease Diagnostic Testing Revenue
• 1.4 Market by Type
  • 1.4.1 Global Infectious Disease Diagnostic Testing Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Molecular Diagnostic Test
  • 1.4.3 POC Infectious Disease Diagnostics Test
• 1.5 Market by Application
  • 1.5.1 Global Infectious Disease Diagnostic Testing Market Share by Application: 2020 VS 2026
  • 1.5.2 HIV
  • 1.5.3 HAIs
  • 1.5.4 Respiratory
  • 1.5.5 Tropical Diseases
  • 1.5.6 Liver
  • 1.5.7 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Infectious Disease Diagnostic Testing Market Perspective (2015-2026)
• 2.2 Global Infectious Disease Diagnostic Testing Growth Trends by Regions
  • 2.2.1 Infectious Disease Diagnostic Testing Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Infectious Disease Diagnostic Testing Historic Market Share by Regions (2015-2020)
  • 2.2.3 Infectious Disease Diagnostic Testing Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Infectious Disease Diagnostic Testing Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Infectious Disease Diagnostic Testing Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Infectious Disease Diagnostic Testing Players by Market Size
  • 3.1.1 Global Top Infectious Disease Diagnostic Testing Players by Revenue (2015-2020)
  • 3.1.2 Global Infectious Disease Diagnostic Testing Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Infectious Disease Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Infectious Disease Diagnostic Testing Market Concentration Ratio
  • 3.2.1 Global Infectious Disease Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Infectious Disease Diagnostic Testing Revenue in 2019
• 3.3 Infectious Disease Diagnostic Testing Key Players Head office and Area Served
• 3.4 Key Players Infectious Disease Diagnostic Testing Product Solution and Service
• 3.5 Date of Enter into Infectious Disease Diagnostic Testing Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Infectious Disease Diagnostic Testing Historic Market Size by Type (2015-2020)
• 4.2 Global Infectious Disease Diagnostic Testing Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Infectious Disease Diagnostic Testing Market Size by Application (2015-2020)
• 5.2 Global Infectious Disease Diagnostic Testing Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Infectious Disease Diagnostic Testing Market Size (2015-2020)
• 6.2 Infectious Disease Diagnostic Testing Key Players in North America (2019-2020)
• 6.3 North America Infectious Disease Diagnostic Testing Market Size by Type (2015-2020)
• 6.4 North America Infectious Disease Diagnostic Testing Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Infectious Disease Diagnostic Testing Market Size (2015-2020)
• 7.2 Infectious Disease Diagnostic Testing Key Players in Europe (2019-2020)
• 7.3 Europe Infectious Disease Diagnostic Testing Market Size by Type (2015-2020)
• 7.4 Europe Infectious Disease Diagnostic Testing Market Size by Application (2015-2020)

8 China

• 8.1 China Infectious Disease Diagnostic Testing Market Size (2015-2020)
• 8.2 Infectious Disease Diagnostic Testing Key Players in China (2019-2020)
• 8.3 China Infectious Disease Diagnostic Testing Market Size by Type (2015-2020)
• 8.4 China Infectious Disease Diagnostic Testing Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Infectious Disease Diagnostic Testing Market Size (2015-2020)
• 9.2 Infectious Disease Diagnostic Testing Key Players in Japan (2019-2020)
• 9.3 Japan Infectious Disease Diagnostic Testing Market Size by Type (2015-2020)
• 9.4 Japan Infectious Disease Diagnostic Testing Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Infectious Disease Diagnostic Testing Market Size (2015-2020)
• 10.2 Infectious Disease Diagnostic Testing Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Infectious Disease Diagnostic Testing Market Size by Type (2015-2020)
• 10.4 Southeast Asia Infectious Disease Diagnostic Testing Market Size by Application (2015-2020)

11 India

• 11.1 India Infectious Disease Diagnostic Testing Market Size (2015-2020)
• 11.2 Infectious Disease Diagnostic Testing Key Players in India (2019-2020)
• 11.3 India Infectious Disease Diagnostic Testing Market Size by Type (2015-2020)
• 11.4 India Infectious Disease Diagnostic Testing Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Infectious Disease Diagnostic Testing Market Size (2015-2020)
• 12.2 Infectious Disease Diagnostic Testing Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Infectious Disease Diagnostic Testing Market Size by Type (2015-2020)
• 12.4 Central & South America Infectious Disease Diagnostic Testing Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Abbott
  • 13.1.1 Abbott Company Details
  • 13.1.2 Abbott Business Overview
  • 13.1.3 Abbott Infectious Disease Diagnostic Testing Introduction
  • 13.1.4 Abbott Revenue in Infectious Disease Diagnostic Testing Business (2015-2020))
  • 13.1.5 Abbott Recent Development
• 13.2 Abbott
  • 13.2.1 Abbott Company Details
  • 13.2.2 Abbott Business Overview
  • 13.2.3 Abbott Infectious Disease Diagnostic Testing Introduction
  • 13.2.4 Abbott Revenue in Infectious Disease Diagnostic Testing Business (2015-2020)
  • 13.2.5 Abbott Recent Development
• 13.3 bioMerieux
  • 13.3.1 bioMerieux Company Details
  • 13.3.2 bioMerieux Business Overview
  • 13.3.3 bioMerieux Infectious Disease Diagnostic Testing Introduction
  • 13.3.4 bioMerieux Revenue in Infectious Disease Diagnostic Testing Business (2015-2020)
  • 13.3.5 bioMerieux Recent Development
• 13.4 Diasorin
  • 13.4.1 Diasorin Company Details
  • 13.4.2 Diasorin Business Overview
  • 13.4.3 Diasorin Infectious Disease Diagnostic Testing Introduction
  • 13.4.4 Diasorin Revenue in Infectious Disease Diagnostic Testing Business (2015-2020)
  • 13.4.5 Diasorin Recent Development
• 13.5 Roche Diagnostic
  • 13.5.1 Roche Diagnostic Company Details
  • 13.5.2 Roche Diagnostic Business Overview
  • 13.5.3 Roche Diagnostic Infectious Disease Diagnostic Testing Introduction
  • 13.5.4 Roche Diagnostic Revenue in Infectious Disease Diagnostic Testing Business (2015-2020)
  • 13.5.5 Roche Diagnostic Recent Development
• 13.6 BD
  • 13.6.1 BD Company Details
  • 13.6.2 BD Business Overview
  • 13.6.3 BD Infectious Disease Diagnostic Testing Introduction
  • 13.6.4 BD Revenue in Infectious Disease Diagnostic Testing Business (2015-2020)
  • 13.6.5 BD Recent Development
• 13.7 Gold Standard Diagnostics
  • 13.7.1 Gold Standard Diagnostics Company Details
  • 13.7.2 Gold Standard Diagnostics Business Overview
  • 13.7.3 Gold Standard Diagnostics Infectious Disease Diagnostic Testing Introduction
  • 13.7.4 Gold Standard Diagnostics Revenue in Infectious Disease Diagnostic Testing Business (2015-2020)
  • 13.7.5 Gold Standard Diagnostics Recent Development
• 13.8 Hologic
  • 13.8.1 Hologic Company Details
  • 13.8.2 Hologic Business Overview
  • 13.8.3 Hologic Infectious Disease Diagnostic Testing Introduction
  • 13.8.4 Hologic Revenue in Infectious Disease Diagnostic Testing Business (2015-2020)
  • 13.8.5 Hologic Recent Development
• 13.9 Siemens Healthcare Diagnostics
  • 13.9.1 Siemens Healthcare Diagnostics Company Details
  • 13.9.2 Siemens Healthcare Diagnostics Business Overview
  • 13.9.3 Siemens Healthcare Diagnostics Infectious Disease Diagnostic Testing Introduction
  • 13.9.4 Siemens Healthcare Diagnostics Revenue in Infectious Disease Diagnostic Testing Business (2015-2020)
  • 13.9.5 Siemens Healthcare Diagnostics Recent Development
• 13.10 TECHLAB
  • 13.10.1 TECHLAB Company Details
  • 13.10.2 TECHLAB Business Overview
  • 13.10.3 TECHLAB Infectious Disease Diagnostic Testing Introduction
  • 13.10.4 TECHLAB Revenue in Infectious Disease Diagnostic Testing Business (2015-2020)
  • 13.10.5 TECHLAB Recent Development
• 13.11 Bio-Rad Laboratories
  • 10.11.1 Bio-Rad Laboratories Company Details
  • 10.11.2 Bio-Rad Laboratories Business Overview
  • 10.11.3 Bio-Rad Laboratories Infectious Disease Diagnostic Testing Introduction
  • 10.11.4 Bio-Rad Laboratories Revenue in Infectious Disease Diagnostic Testing Business (2015-2020)
  • 10.11.5 Bio-Rad Laboratories Recent Development
• 13.12 Corgenix
  • 10.12.1 Corgenix Company Details
  • 10.12.2 Corgenix Business Overview
  • 10.12.3 Corgenix Infectious Disease Diagnostic Testing Introduction
  • 10.12.4 Corgenix Revenue in Infectious Disease Diagnostic Testing Business (2015-2020)
  • 10.12.5 Corgenix Recent Development
• 13.13 Cepheid
  • 10.13.1 Cepheid Company Details
  • 10.13.2 Cepheid Business Overview
  • 10.13.3 Cepheid Infectious Disease Diagnostic Testing Introduction
  • 10.13.4 Cepheid Revenue in Infectious Disease Diagnostic Testing Business (2015-2020)
  • 10.13.5 Cepheid Recent Development
• 13.14 Meridian Bioscience
  • 10.14.1 Meridian Bioscience Company Details
  • 10.14.2 Meridian Bioscience Business Overview
  • 10.14.3 Meridian Bioscience Infectious Disease Diagnostic Testing Introduction
  • 10.14.4 Meridian Bioscience Revenue in Infectious Disease Diagnostic Testing Business (2015-2020)
  • 10.14.5 Meridian Bioscience Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer